1. |
Questions over SPf66 malaria vaccine in children |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1090KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
2. |
Bounty from the sea - potential antineoplastic agents discovered |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 3-4
Gill Higgins,
Preview
|
PDF (2195KB)
|
|
摘要:
At present, the seas are an untapped resource for the pharmaceutical industry, but this may not be the case for long. Several companies have begun to show interest in the pharmacological properties of chemicals extracted from marine life and some, such as the Spanish company Pharma Mar, are actively investigating hundreds of potential agents. The results of preclinical studies with several of Pharma Mar's leading marine-derived candidates were presented at the European Cancer Conference [Paris, France; October/November 1995], along with data from studies of new antineoplastic agents from other sources.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
3. |
Better hepatitis B vaccine coverage needed in the US |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 4-4
&NA;,
Preview
|
PDF (1059KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
4. |
Improving care with clinical guidelines and practice-based education |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 5-5
&NA;,
Preview
|
PDF (981KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
5. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1028KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
6. |
No crystal ball available? Try guesswork + benchmarking |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 7-7
Tracey Langsdale,
Preview
|
PDF (1038KB)
|
|
摘要:
How can we assess the economic impact of individual patient care decisions, asks Dr Joseph Paladino from the Millard Fillmore Health System in New York, US. The economic methodologies and guidelines currently available are not designed to answer this question. Yet this information is what hospitals and third-party payers want to know. Attendees at the 30th Annual American Society of Health System Pharmacists Mid-year Clinical Meeting [Las Vegas, US; December 1995] heard how Dr Paladino tackles this question at his institution.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
7. |
Promising results with dofetilide in life-threatening arrhythmias |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1023KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
8. |
Tazarotene heads for success in psoriasis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 9-10
Rodger Hall,
Preview
|
PDF (2184KB)
|
|
摘要:
The full results of a double-blind, phase III study of tazarotene involving patients with psoriasis were presented at this year's Dermatology Update [Montreal, Canada; October 1995]. The data showed that tazarotene gel significantly reduced lesion development, compared with placebo, and was well tolerated. These results bode well for the new retinoid, which was submitted to the US FDA in June 1995 for marketing approval as a treatment for acne and psoriasis.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 10-10
&NA;,
Preview
|
PDF (1042KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
10. |
PMPA gives 100% protection from SIV |
|
Inpharma Weekly,
Volume &NA;,
Issue 1017,
1995,
Page 11-11
&NA;,
Preview
|
PDF (1016KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|